Year |
Citation |
Score |
2019 |
Wilkerson JL, Felix JS, Restrepo LF, Ansari MI, Coop A, McMahon LR. The Effects of Morphine, Baclofen, and Buspirone Alone and in Combination on Schedule-Controlled Responding and Hot Plate Antinociception in Rats. The Journal of Pharmacology and Experimental Therapeutics. PMID 31235534 DOI: 10.1124/Jpet.118.255844 |
0.306 |
|
2018 |
Ansari MI, Healy JR, Hom K, Deschamps JR, Matsumoto RR, Coop A. Synthesis and Structural Elucidation of a Pyranomorphinan Opioid and in Vitro Studies. Organic Letters. PMID 29737176 DOI: 10.1021/acs.orglett.8b01025 |
0.351 |
|
2016 |
Healy JR, Bezawada P, Griggs NW, Devereaux AL, Matsumoto RR, Traynor JR, Coop A, Cunningham CW. Benzylideneoxymorphone: A new lead for development of bifunctional mu/delta opioid receptor ligands. Bioorganic & Medicinal Chemistry Letters. PMID 28011222 DOI: 10.1016/j.bmcl.2016.11.057 |
0.673 |
|
2014 |
Cunningham CW, Deschamps JR, Coop A. A One-Step Synthesis of -Bromocodide from Codeine. Journal of Pharmaceutical Sciences and Pharmacology. 1: 54-56. PMID 34584903 |
0.595 |
|
2014 |
Ben Haddou T, Malfacini D, Calo G, Aceto MD, Harris LS, Traynor JR, Coop A, Schmidhammer H, Spetea M. Exploring pharmacological activities and signaling of morphinans substituted in position 6 as potent agonists interacting with the μ opioid receptor. Molecular Pain. 10: 48. PMID 25059282 DOI: 10.1186/1744-8069-10-48 |
0.436 |
|
2014 |
Metcalf MD, Rosicky AD, Hassan HE, Eddington ND, Coop A, Cunningham CW, Mercer SL. Opioids and efflux transporters. Part 4: influence of N-substitution on P-glycoprotein substrate activity of noroxymorphone analogues. Bioorganic & Medicinal Chemistry Letters. 24: 3592-5. PMID 24915880 DOI: 10.1016/J.Bmcl.2014.05.033 |
0.774 |
|
2014 |
Cunningham CW, Deschamps JR, Coop A. A One-Step Synthesis of -Bromocodide from Codeine Journal of Pharmaceutical Sciences and Pharmacology. 1: 54-56. DOI: 10.1166/jpsp.2014.1005 |
0.501 |
|
2013 |
Stavitskaya L, Seminerio MJ, Healy JR, Noorbakhsh B, Matsumoto RR, Coop A. Effect of ring-constrained phenylpropyloxyethylamines on sigma receptors. Bioorganic & Medicinal Chemistry. 21: 4923-7. PMID 23896610 DOI: 10.1016/J.Bmc.2013.06.068 |
0.761 |
|
2013 |
Shim J, Coop A, MacKerell AD. Molecular details of the activation of the μ opioid receptor. The Journal of Physical Chemistry. B. 117: 7907-17. PMID 23758404 DOI: 10.1021/Jp404238N |
0.45 |
|
2013 |
Robson MJ, Seminerio MJ, McCurdy CR, Coop A, Matsumoto RR. σ Receptor antagonist attenuation of methamphetamine-induced neurotoxicity is correlated to body temperature modulation. Pharmacological Reports : Pr. 65: 343-9. PMID 23744418 DOI: 10.1016/S1734-1140(13)71009-0 |
0.384 |
|
2013 |
Healy JR, Bezawada P, Shim J, Jones JW, Kane MA, MacKerell AD, Coop A, Matsumoto RR. Synthesis, modeling, and pharmacological evaluation of UMB 425, a mixed μ agonist/δ antagonist opioid analgesic with reduced tolerance liabilities. Acs Chemical Neuroscience. 4: 1256-66. PMID 23713721 DOI: 10.1021/Cn4000428 |
0.508 |
|
2013 |
Motel WC, Coop A, Cunningham CW. Cholinergic modulation by opioid receptor ligands: potential application to Alzheimer's disease. Mini Reviews in Medicinal Chemistry. 13: 456-66. PMID 22931533 DOI: 10.2174/138955713804999784 |
0.663 |
|
2012 |
Stavitskaya L, Shim J, Healy JR, Matsumoto RR, MacKerell AD, Coop A. Deconstructing 14-phenylpropyloxymetopon: minimal requirements for binding to mu opioid receptors. Bioorganic & Medicinal Chemistry. 20: 4556-63. PMID 22677527 DOI: 10.1016/J.Bmc.2012.05.006 |
0.785 |
|
2011 |
Stavitskaya L, Coop A. Most recent developments and modifications of 14-alkylamino and 14-alkoxy-4,5-epoxymorphinan derivatives. Mini Reviews in Medicinal Chemistry. 11: 1002-8. PMID 21861811 DOI: 10.2174/138955711797247752 |
0.73 |
|
2011 |
Shim J, Coop A, MacKerell AD. Consensus 3D model of μ-opioid receptor ligand efficacy based on a quantitative Conformationally Sampled Pharmacophore. The Journal of Physical Chemistry. B. 115: 7487-96. PMID 21563754 DOI: 10.1021/Jp202542G |
0.492 |
|
2011 |
Mercer SL, Coop A. Opioid analgesics and P-glycoprotein efflux transporters: a potential systems-level contribution to analgesic tolerance. Current Topics in Medicinal Chemistry. 11: 1157-64. PMID 21050174 DOI: 10.2174/156802611795371288 |
0.728 |
|
2011 |
Follia V, Aceto MD, Harris LS, Coop A, Schmidhammer H, Spetea M. Introduction of a 6-cyano group in 14-oxygenated N-methylmorphinans influences in vitro and in vivo pharmacological activities Bmc Pharmacology. 11: A26. DOI: 10.1186/1471-2210-11-S2-A26 |
0.382 |
|
2011 |
Shim J, Coop A, MacKerell AD. Identification of an Efficacy Pharmacophore for μ Opioid Receptor Ligands Using the Conformationally Sampled Pharmacophore (CSP) Method Biophysical Journal. 100: 549a. DOI: 10.1016/J.Bpj.2010.12.3198 |
0.49 |
|
2010 |
Cunningham CW, Hom K, Acharya C, Wilks A, Mackerell AD, Coop A. Synthesis and Characterization of a Novel Diels - Alder Adduct of Codeine. Helvetica Chimica Acta. 93: 220-226. PMID 23378668 DOI: 10.1002/Hlca.200900234 |
0.576 |
|
2010 |
Stavitskaya L, Seminerio MJ, Matthews-Tsourounis MM, Matsumoto RR, Coop A. The effect of the pyridyl nitrogen position in pyridylpiperazine sigma ligands. Bioorganic & Medicinal Chemistry Letters. 20: 2564-5. PMID 20338757 DOI: 10.1016/J.Bmcl.2010.02.087 |
0.727 |
|
2009 |
Koek W, Mercer SL, Coop A, France CP. Behavioral effects of gamma-hydroxybutyrate, its precursor gamma-butyrolactone, and GABA(B) receptor agonists: time course and differential antagonism by the GABA(B) receptor antagonist 3-aminopropyl(diethoxymethyl)phosphinic acid (CGP35348). The Journal of Pharmacology and Experimental Therapeutics. 330: 876-83. PMID 19564487 DOI: 10.1124/Jpet.109.151845 |
0.635 |
|
2009 |
Hassan HE, Mercer SL, Cunningham CW, Coop A, Eddington ND. Evaluation of the P-glycoprotein (Abcb1) affinity status of a series of morphine analogs: comparative study with meperidine analogs to identify opioids with minimal P-glycoprotein interactions. International Journal of Pharmaceutics. 375: 48-54. PMID 19481690 DOI: 10.1016/J.Ijpharm.2009.03.037 |
0.776 |
|
2008 |
Mercer SL, Cunningham CW, Eddington ND, Coop A. Opioids and efflux transporters. Part 3: P-glycoprotein substrate activity of 3-hydroxyl addition to meperidine analogs. Bioorganic & Medicinal Chemistry Letters. 18: 3638-40. PMID 18499452 DOI: 10.1016/J.Bmcl.2008.04.046 |
0.767 |
|
2008 |
Smith TA, Yang X, Wu H, Pouw B, Matsumoto RR, Coop A. Trifluoromethoxyl substituted phenylethylene diamines as high affinity sigma receptor ligands with potent anti-cocaine actions. Journal of Medicinal Chemistry. 51: 3322-5. PMID 18461921 DOI: 10.1021/Jm7013666 |
0.377 |
|
2008 |
Cunningham CW, Mercer SL, Hassan HE, Traynor JR, Eddington ND, Coop A. Opioids and efflux transporters. Part 2: P-glycoprotein substrate activity of 3- and 6-substituted morphine analogs. Journal of Medicinal Chemistry. 51: 2316-20. PMID 18311899 DOI: 10.1021/Jm701457J |
0.79 |
|
2008 |
Mercer SL, Shaikh J, Traynor JR, Matsumoto RR, Coop A. Nitrile analogs of meperidine as high affinity and selective sigma-1 receptor ligands. European Journal of Medicinal Chemistry. 43: 1304-8. PMID 17988766 DOI: 10.1016/J.Ejmech.2007.09.026 |
0.698 |
|
2008 |
Metcalf MD, Aceto MD, Harris LS, Woods JH, Traynor JR, Coop A, May EL. The influence of esters and carboxylic acids as the N-substituent of opioids. Part 1: Benzomorphans. Bioorganic & Medicinal Chemistry. 16: 869-73. PMID 17962026 DOI: 10.1016/j.bmc.2007.10.030 |
0.579 |
|
2007 |
Metcalf MD, Coop A. 5'-halogenated analogs of oxymorphindole. Bioorganic & Medicinal Chemistry Letters. 17: 5916-7. PMID 17826993 DOI: 10.1016/j.bmcl.2007.07.098 |
0.414 |
|
2007 |
Smith TA, Thatcher LN, Coop A. 3-Hydroxy-4-methoxyindolomorphinans as delta opioid selective ligands. Bioorganic & Medicinal Chemistry Letters. 17: 5175-6. PMID 17659872 DOI: 10.1016/j.bmcl.2007.06.087 |
0.377 |
|
2007 |
Hiebel AC, Lee YS, Bilsky E, Giuvelis D, Deschamps JR, Parrish DA, Aceto MD, May EL, Harris LS, Coop A, Dersch CM, Partilla JS, Rothman RB, Cheng K, Jacobson AE, et al. Probes for narcotic receptor mediated phenomena. 34. Synthesis and structure-activity relationships of a potent mu-agonist delta-antagonist and an exceedingly potent antinociceptive in the enantiomeric C9-substituted 5-(3-hydroxyphenyl)-N-phenylethylmorphan series. Journal of Medicinal Chemistry. 50: 3765-76. PMID 17625813 DOI: 10.1021/Jm061325E |
0.647 |
|
2007 |
Wu H, Smith TA, Huang H, Wang JB, Deschamps JR, Coop A. Functionalization of the 6,14-bridge of the orvinols. Part 3: preparation and pharmacological evaluation of 18- and 19-hydroxyl substituted orvinols. Bioorganic & Medicinal Chemistry Letters. 17: 4829-31. PMID 17601735 DOI: 10.1016/j.bmcl.2007.06.050 |
0.381 |
|
2007 |
Hassan HE, Myers AL, Lee IJ, Coop A, Eddington ND. Oxycodone induces overexpression of P-glycoprotein (ABCB1) and affects paclitaxel's tissue distribution in Sprague Dawley rats. Journal of Pharmaceutical Sciences. 96: 2494-506. PMID 17593551 DOI: 10.1002/Jps.20893 |
0.312 |
|
2007 |
Cheng K, Kim IJ, Lee MJ, Adah SA, Raymond TJ, Bilsky EJ, Aceto MD, May EL, Harris LS, Coop A, Dersch CM, Rothman RB, Jacobson AE, Rice KC. Opioid ligands with mixed properties from substituted enantiomeric N-phenethyl-5-phenylmorphans. Synthesis of a micro-agonist delta-antagonist and delta-inverse agonists. Organic & Biomolecular Chemistry. 5: 1177-90. PMID 17406716 DOI: 10.1039/B618875C |
0.699 |
|
2007 |
Bernard D, Coop A, MacKerell AD. Quantitative conformationally sampled pharmacophore for delta opioid ligands: reevaluation of hydrophobic moieties essential for biological activity. Journal of Medicinal Chemistry. 50: 1799-809. PMID 17367120 DOI: 10.1021/jm0612463 |
0.378 |
|
2007 |
Koek W, Mercer SL, Coop A. Cataleptic effects of gamma-hydroxybutyrate (GHB), its precursor gamma-butyrolactone (GBL), and GABAB receptor agonists in mice: differential antagonism by the GABAB receptor antagonist CGP35348. Psychopharmacology. 192: 407-14. PMID 17277933 DOI: 10.1007/S00213-007-0718-Y |
0.666 |
|
2007 |
Mercer SL, Hassan HE, Cunningham CW, Eddington ND, Coop A. Opioids and efflux transporters. Part 1: P-glycoprotein substrate activity of N-substituted analogs of meperidine. Bioorganic & Medicinal Chemistry Letters. 17: 1160-2. PMID 17251015 DOI: 10.1016/J.Bmcl.2006.12.042 |
0.764 |
|
2007 |
Newman AH, Coop A. Medicinal chemistry: New chemical classes and subtype-selective ligands Sigma Receptors: Chemistry, Cell Biology and Clinical Implications. 25-44. DOI: 10.1007/978-0-387-36514-5_2 |
0.416 |
|
2006 |
Fantegrossi WE, Harrington AW, Kiessel CL, Eckler JR, Rabin RA, Winter JC, Coop A, Rice KC, Woods JH. Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats. Pharmacology, Biochemistry, and Behavior. 83: 122-9. PMID 16460788 DOI: 10.1016/J.Pbb.2005.12.015 |
0.388 |
|
2006 |
Koek W, Chen W, Mercer SL, Coop A, France CP. Discriminative stimulus effects of gamma-hydroxybutyrate: role of training dose. The Journal of Pharmacology and Experimental Therapeutics. 317: 409-17. PMID 16330491 DOI: 10.1124/Jpet.105.096909 |
0.624 |
|
2006 |
Cunningham CW, Thatcher LN, Coop A. Methylation of non-acidic alcohols of alkaloids with TMS-diazomethane: Conversion of codeine to codeine-6-methyl ether Heterocycles. 68: 837-840. DOI: 10.3987/Com-06-10694 |
0.544 |
|
2006 |
Cunningham CW, Coop A. Therapeutic applications of opioid antagonists Chimica Oggi. 24: 54-57. |
0.646 |
|
2005 |
Metcalf MD, Coop A. Kappa opioid antagonists: past successes and future prospects. The Aaps Journal. 7: E704-22. PMID 16353947 DOI: 10.1208/aapsj070371 |
0.413 |
|
2005 |
Bernard D, Coop A, MacKerell Jr AD. Conformationally sampled pharmacophore for peptidic delta opioid ligands. Journal of Medicinal Chemistry. 48: 7773-80. PMID 16302816 DOI: 10.1021/jm050785p |
0.356 |
|
2005 |
Spetea M, Greiner E, Aceto MD, Harris LS, Coop A, Schmidhammer H. Effect of a 6-cyano substituent in 14-oxygenated N-methylmorphinans on opioid receptor binding and antinociceptive potency. Journal of Medicinal Chemistry. 48: 5052-5. PMID 16033285 DOI: 10.1021/jm0580205 |
0.44 |
|
2005 |
Fantegrossi WE, Harrington AW, Eckler JR, Arshad S, Rabin RA, Winter JC, Coop A, Rice KC, Woods JH. Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats. Psychopharmacology. 181: 496-503. PMID 15983786 DOI: 10.1007/S00213-005-0009-4 |
0.38 |
|
2005 |
Wu H, Thatcher LN, Bernard D, Parrish DA, Deschamps JR, Rice KC, MacKerell AD, Coop A. Position of coordination of the lithium ion determines the regioselectivity of demethylations of 3,4-dimethoxymorphinans with L-selectride. Organic Letters. 7: 2531-4. PMID 15957883 DOI: 10.1021/Ol050433C |
0.46 |
|
2005 |
Wu H, Bernard D, Chen W, Strahan GD, Deschamps JR, Parrish DA, Lewis JW, MacKerell AD, Coop A. Functionalization of the 6,14-bridge of the orvinols. 2. Preparation of 18- and 19-hydroxyl-substituted thevinols and their treatment with benzyl bromide. The Journal of Organic Chemistry. 70: 1907-10. PMID 15730320 DOI: 10.1021/Jo048388U |
0.484 |
|
2005 |
Bernard D, Coop A, MacKerell AD. Computer-aided drug design: Structure-activity relationships of delta opioid ligands Drug Design Reviews Online. 2: 277-291. DOI: 10.2174/1567269054087596 |
0.385 |
|
2004 |
Spetea M, Schüllner F, Moisa RC, Berzetei-Gurske IP, Schraml B, Dörfler C, Aceto MD, Harris LS, Coop A, Schmidhammer H. Synthesis and biological evaluation of 14-alkoxymorphinans. 21. Novel 4-alkoxy and 14-phenylpropoxy derivatives of the mu opioid receptor antagonist cyprodime. Journal of Medicinal Chemistry. 47: 3242-7. PMID 15163203 DOI: 10.1021/jm031126k |
0.424 |
|
2004 |
Calderon SN, Coop A. SNC 80 and related delta opioid agonists. Current Pharmaceutical Design. 10: 733-42. PMID 15032699 DOI: 10.2174/1381612043453054 |
0.381 |
|
2004 |
Deschamps JR, Coop A, Parrish DA, Rice KC. 7β,14β-Epoxyhydrocodone-6,6-dimethoxy ketal: An unusual oxetane-containing opioid Acta Crystallographica Section E: Structure Reports Online. 60: o331-o333. DOI: 10.1107/S1600536804002077 |
0.404 |
|
2003 |
Schütz J, Spetea M, Koch M, Aceto MD, Harris LS, Coop A, Schmidhammer H. Synthesis and biological evaluation of 14-alkoxymorphinans. 20. 14-phenylpropoxymetopon: an extremely powerful analgesic. Journal of Medicinal Chemistry. 46: 4182-7. PMID 12954070 DOI: 10.1021/jm030878b |
0.375 |
|
2003 |
Janetka JW, Furness MS, Zhang X, Coop A, Folk JE, Mattson MV, Jacobson AE, Rice KC. Enantioconvergent synthesis of (-)-(2R,5S)-1-allyl-2,5-dimethylpiperazine, an intermediate to δ-opioid receptor ligands Journal of Organic Chemistry. 68: 3976-3980. PMID 12737580 DOI: 10.1021/Jo0300385 |
0.732 |
|
2003 |
Greiner E, Spetea M, Krassnig R, Schüllner F, Aceto M, Harris LS, Traynor JR, Woods JH, Coop A, Schmidhammer H. Synthesis and biological evaluation of 14-alkoxymorphinans. 18. N-substituted 14-phenylpropyloxymorphinan-6-ones with unanticipated agonist properties: extending the scope of common structure-activity relationships. Journal of Medicinal Chemistry. 46: 1758-63. PMID 12699394 DOI: 10.1021/jm021118o |
0.424 |
|
2003 |
Bernard D, Coop A, MacKerell AD. 2D conformationally sampled pharmacophore: a ligand-based pharmacophore to differentiate delta opioid agonists from antagonists. Journal of the American Chemical Society. 125: 3101-7. PMID 12617677 DOI: 10.1021/Ja027644M |
0.437 |
|
2003 |
May EL, Coop A, Woods JH, Aceto MD, Bowman ER, Harris LS, Traynor JR. N-(trifluoromethyl)benzyl substituted N-normetazocines and N-norketobemidones. Bioorganic & Medicinal Chemistry. 11: 31-3. PMID 12467704 DOI: 10.1016/S0968-0896(02)00435-2 |
0.605 |
|
2002 |
Hsin LW, Tian X, Webster EL, Coop A, Caldwell TM, Jacobson AE, Chrousos GP, Gold PW, Habib KE, Ayala A, Eckelman WC, Contoreggi C, Rice KC. CRHR1 Receptor binding and lipophilicity of pyrrolopyrimidines, potential nonpeptide corticotropin-releasing hormone type 1 receptor antagonists. Bioorganic & Medicinal Chemistry. 10: 175-83. PMID 11738619 DOI: 10.1016/S0968-0896(01)00261-9 |
0.548 |
|
2002 |
Coop A, MacKerell AD. The future of opioid analgesics American Journal of Pharmaceutical Education. 66: 153-156. |
0.346 |
|
2001 |
McLamore S, Ullrich T, Rothman RB, Xu H, Dersch C, Coop A, Davis P, Porreca F, Jacobson AE, Rice KC. Effect of N-alkyl and N-alkenyl substituents in noroxymorphindole, 17-substituted-6,7-dehydro-4,5alpha-epoxy-3,14-dihydroxy-6,7:2',3'-indolomorphinans, on opioid receptor affinity, selectivity, and efficacy. Journal of Medicinal Chemistry. 44: 1471-4. PMID 11311071 DOI: 10.1021/Jm000511W |
0.542 |
|
2000 |
Coop A, Rice KC. Role of delta-opioid receptors in biological processes. Drug News & Perspectives. 13: 481-7. PMID 12937621 |
0.386 |
|
2000 |
Coop A, Jacobson AE, Aceto MD, Harris LS, Traynor JR, Woods JH, Rice KC. N-Cyclohexylethyl-N-noroxymorphindole: a mu-opioid preferring analogue of naltrindole. Bioorganic & Medicinal Chemistry Letters. 10: 2449-51. PMID 11078198 DOI: 10.1016/S0960-894X(00)00479-0 |
0.55 |
|
2000 |
Furness MS, Zhang X, Coop A, Jacobson AE, Rothman RB, Dersch CM, Xu H, Porreca F, Rice KC. Probes for narcotic receptor-mediated phenomena. 27. Synthesis and pharmacological evaluation of selective delta-opioid receptor agonists from 4-[(alphaR)-alpha-(2S,5R)-4-substituted-2, 5-dimethyl-1-piperazinyl-3-methoxybenzyl]-N,N-diethylbenzamides and their enantiomers. Journal of Medicinal Chemistry. 43: 3193-6. PMID 10956228 DOI: 10.1021/Jm0001222 |
0.583 |
|
2000 |
Broom DC, Guo L, Coop A, Husbands SM, Lewis JW, Woods JH, Traynor JR. BU48: a novel buprenorphine analog that exhibits delta-opioid-mediated convulsions but not delta-opioid-mediated antinociception in mice. The Journal of Pharmacology and Experimental Therapeutics. 294: 1195-200. PMID 10945877 |
0.605 |
|
2000 |
Coop A, Norton CL, Berzetei-Gurske I, Burnside J, Toll L, Husbands SM, Lewis JW. Structural determinants of opioid activity in the orvinols and related structures: ethers of orvinol and isoorvinol. Journal of Medicinal Chemistry. 43: 1852-7. PMID 10794701 DOI: 10.1021/Jm990951R |
0.6 |
|
2000 |
Maeda DY, Williams W, Bowen WD, Coop A. A sigma-1 receptor selective analogue of BD1008. A potential substitute for (+)-opioids in sigma receptor binding assays. Bioorganic & Medicinal Chemistry Letters. 10: 17-8. PMID 10636233 DOI: 10.1016/S0960-894X(99)00590-9 |
0.463 |
|
2000 |
Derrick I, Coop A, Al-Mousawi SM, Husbands SM, Lewis JW. Perchloric acid induced epimerisation of the thevinones: An improved synthesis of 7β-dihydrothevinones Tetrahedron Letters. 41: 7571-7576. DOI: 10.1016/S0040-4039(00)01300-9 |
0.543 |
|
2000 |
Coop A, Berzetei-Gurske I, Burnside J, Toll L, Traynor JR, Husbands SM, Lewis JW. Structural determinants of opioid activity in the orvinols and related structures. Ethers of 7,8-cyclopenta-fused analogs of buprenorphine Helvetica Chimica Acta. 83: 687-693. DOI: 10.1002/(Sici)1522-2675(20000412)83:4<687::Aid-Hlca687>3.0.Co;2-W |
0.605 |
|
2000 |
Coop A, Rice KC. Role of δ-opioid receptors in biological processes Drug News and Perspectives. 13: 481-487. |
0.363 |
|
1999 |
Zhang X, Rice KC, Calderon SN, Kayakiri H, Smith L, Coop A, Jacobson AE, Rothman RB, Davis P, Dersch CM, Porreca F. Probes for narcotic receptor mediated phenomena. 26. Synthesis and biological evaluation of diarylmethylpiperazines and diarylmethylpiperidines as novel, nonpeptidic delta opioid receptor ligands. Journal of Medicinal Chemistry. 42: 5455-63. PMID 10639287 DOI: 10.1021/Jm9903895 |
0.507 |
|
1999 |
Coop A, Pinto J, Wang L, McCullough K, Rothman RB, Dersch C, Jacobson AE, Rice KC. Delta opioid binding selectivity of 3-ether analogs of naltrindole. Bioorganic & Medicinal Chemistry Letters. 9: 3435-8. PMID 10617086 DOI: 10.1016/S0960-894X(99)00622-8 |
0.574 |
|
1999 |
Traynor JR, Guo L, Coop A, Lewis JW, Woods JH. Ring-constrained orvinols as analogs of buprenorphine: differences in opioid activity related to configuration of C(20) hydroxyl group. The Journal of Pharmacology and Experimental Therapeutics. 291: 1093-9. PMID 10565829 |
0.592 |
|
1999 |
Coop A, Rothman RB, Dersch C, Partilla J, Porreca F, Davis P, Jacobson AE, Rice KC. delta Opioid affinity and selectivity of 4-hydroxy-3-methoxyindolomorphinan analogues related to naltrindole. Journal of Medicinal Chemistry. 42: 1673-9. PMID 10229636 DOI: 10.1021/Jm9807003 |
0.559 |
|
1999 |
Coop A, Jacobson AE. The LMC delta opioid recognition pharmacophore: comparison of SNC80 and oxymorphindole. Bioorganic & Medicinal Chemistry Letters. 9: 357-62. PMID 10091684 DOI: 10.1016/S0960-894X(98)00745-8 |
0.399 |
|
1999 |
Coop A, Rice KC. Direct and Simple Conversion of Codeine to Thebainone-A and Dihydrothebainone Heterocycles. 50: 39-42. DOI: 10.3987/Com-98-S(H)15 |
0.383 |
|
1999 |
Breeden SW, Coop A, Husbands SM, Lewis JW. 6-O-demethylation of the thevinols with lithium aluminium hydride: Selective demethylation of a tertiary alkyl methyl ether in the presence of an aryl methyl ether Helvetica Chimica Acta. 82: 1978-1980. DOI: 10.1002/(Sici)1522-2675(19991110)82:11<1978::Aid-Hlca1978>3.0.Co;2-Q |
0.501 |
|
1998 |
Coop A, Rice KC. A Novel Synthesis Of Thebaine From Codeine Heterocycles. 49: 43-47. DOI: 10.3987/Com-98-S8 |
0.422 |
|
1998 |
Coop A, Janetka JW, Lewis JW, Rice KC. L-Selectride as a general reagent for the O-demethylation and N-decarbomethoxylation of opium alkaloids and derivatives Journal of Organic Chemistry. 63: 4392-4396. DOI: 10.1021/Jo9801972 |
0.724 |
|
1998 |
Coop A, Rice KC. L-Selectride as a convenient reagent for the selective cleavage of carbamates Tetrahedron Letters. 39: 8933-8934. DOI: 10.1016/S0040-4039(98)02018-8 |
0.445 |
|
1998 |
Coop A, Janetka JW, Lewis JW, Rice KC. L-Selectride as a General Reagent for the O-Demethylation and N-Decarbomethoxylation of Opium Alkaloids and Derivatives Journal of Organic Chemistry. 63: 4392-4396. |
0.584 |
|
1998 |
May EL, Jacobson AE, Mattson MV, Coop A, Aceto MD, Bowman ER, Traynor JR, Woods JH, Harris LS. Synthesis, in vitro, and in vivo activity of N-p-substituted-benzyl- (- )- and (+)-N-normetazocines, (-)- and (+)-N-normorphinans, N- norketobemidones, and (-)-N-nor-4,5-epoxymorphinans Medicinal Chemistry Research. 8: 311-321. |
0.469 |
|
1996 |
Coop A, Lewis JW, Rice KC. Direct and Simple O-Demethylation of Thebaine to Oripavine. The Journal of Organic Chemistry. 61: 6774. PMID 11667567 DOI: 10.1021/Jo961473K |
0.539 |
|
1995 |
Guo L, Coop A, Lewis JW, Traynor JR. AFFINITY AND EFFICACY STUDIES OF RING CONSTRAINED ANALOGUES OF BUPRENORPHINE AT μ-OPIOID RECEPTORS. Analgesia. 1: 450-452. DOI: 10.3727/107156995819563915 |
0.412 |
|
1995 |
Coop A, Grivas K, Husbands S, Lewis JW, Porter J. Ring constrained analogues of the thevinones; Diels-Alder reactions of thebaines with 1-indenone and methylene cycloalkanones Tetrahedron Letters. 36: 1689-1692. DOI: 10.1016/0040-4039(95)00046-F |
0.472 |
|
1995 |
Coop A, Grivas K, Husbands S, Lewis JW. Methylation of the enolates of thevinone and some analogues Tetrahedron. 51: 9681-9698. DOI: 10.1016/0040-4020(95)00553-K |
0.475 |
|
1993 |
Barton JW, Coop A, Lewis JW. Diels-Alder reactions of thebaines with cycloalkenones; Lithium tetrafluoroborate as a novel diels-alder catalyst Tetrahedron Letters. 34: 6777-6778. DOI: 10.1016/S0040-4039(00)61699-4 |
0.475 |
|
Show low-probability matches. |